Financhill
Buy
53

XHE Quote, Financials, Valuation and Earnings

Last price:
$79.91
Seasonality move :
-0.55%
Day range:
$79.59 - $80.23
52-week range:
$71.25 - $97.10
Dividend yield:
0.07%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
88.9K
Avg. volume:
20.8K
1-year change:
-8.09%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
XHE
SPDR S&P Health Care Equipment ETF
-- -- -- -- --
FBT
First Trust NYSE Arca Biotechnology Index Fund
-- -- -- -- --
PBE
Invesco Biotechnology & Genome ETF
-- -- -- -- --
PJP
Invesco Pharmaceuticals ETF
-- -- -- -- --
XBI
SPDR S&P Biotech ETF
-- -- -- -- --
XPH
SPDR S&P Pharmaceuticals ETF
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
XHE
SPDR S&P Health Care Equipment ETF
$79.78 -- -- -- $0.02 0.07% --
FBT
First Trust NYSE Arca Biotechnology Index Fund
$165.67 -- -- -- $1.17 0.71% --
PBE
Invesco Biotechnology & Genome ETF
$66.91 -- -- -- $0.13 0.25% --
PJP
Invesco Pharmaceuticals ETF
$83.38 -- -- -- $0.27 1.16% --
XBI
SPDR S&P Biotech ETF
$88.27 -- -- -- $0.01 0.04% --
XPH
SPDR S&P Pharmaceuticals ETF
$42.68 -- -- -- $0.10 1.4% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
XHE
SPDR S&P Health Care Equipment ETF
-- 1.330 -- --
FBT
First Trust NYSE Arca Biotechnology Index Fund
-- 0.653 -- --
PBE
Invesco Biotechnology & Genome ETF
-- 0.915 -- --
PJP
Invesco Pharmaceuticals ETF
-- 0.248 -- --
XBI
SPDR S&P Biotech ETF
-- 1.018 -- --
XPH
SPDR S&P Pharmaceuticals ETF
-- 0.358 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
XHE
SPDR S&P Health Care Equipment ETF
-- -- -- -- -- --
FBT
First Trust NYSE Arca Biotechnology Index Fund
-- -- -- -- -- --
PBE
Invesco Biotechnology & Genome ETF
-- -- -- -- -- --
PJP
Invesco Pharmaceuticals ETF
-- -- -- -- -- --
XBI
SPDR S&P Biotech ETF
-- -- -- -- -- --
XPH
SPDR S&P Pharmaceuticals ETF
-- -- -- -- -- --

SPDR S&P Health Care Equipment ETF vs. Competitors

  • Which has Higher Returns XHE or FBT?

    First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    XHE
    SPDR S&P Health Care Equipment ETF
    -- -- --
    FBT
    First Trust NYSE Arca Biotechnology Index Fund
    -- -- --
  • What do Analysts Say About XHE or FBT?

    SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.

    Company Buy Ratings Hold Ratings Sell Ratings
    XHE
    SPDR S&P Health Care Equipment ETF
    0 0 0
    FBT
    First Trust NYSE Arca Biotechnology Index Fund
    0 0 0
  • Is XHE or FBT More Risky?

    SPDR S&P Health Care Equipment ETF has a beta of 1.047, which suggesting that the stock is 4.673% more volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.641, suggesting its less volatile than the S&P 500 by 35.874%.

  • Which is a Better Dividend Stock XHE or FBT?

    SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.07%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0.71% to investors and pays a quarterly dividend of $1.17 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XHE or FBT?

    SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XHE
    SPDR S&P Health Care Equipment ETF
    -- -- -- --
    FBT
    First Trust NYSE Arca Biotechnology Index Fund
    -- -- -- --
  • Which has Higher Returns XHE or PBE?

    Invesco Biotechnology & Genome ETF has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    XHE
    SPDR S&P Health Care Equipment ETF
    -- -- --
    PBE
    Invesco Biotechnology & Genome ETF
    -- -- --
  • What do Analysts Say About XHE or PBE?

    SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than Invesco Biotechnology & Genome ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    XHE
    SPDR S&P Health Care Equipment ETF
    0 0 0
    PBE
    Invesco Biotechnology & Genome ETF
    0 0 0
  • Is XHE or PBE More Risky?

    SPDR S&P Health Care Equipment ETF has a beta of 1.047, which suggesting that the stock is 4.673% more volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.810, suggesting its less volatile than the S&P 500 by 19.007%.

  • Which is a Better Dividend Stock XHE or PBE?

    SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.07%. Invesco Biotechnology & Genome ETF offers a yield of 0.25% to investors and pays a quarterly dividend of $0.13 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XHE or PBE?

    SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XHE
    SPDR S&P Health Care Equipment ETF
    -- -- -- --
    PBE
    Invesco Biotechnology & Genome ETF
    -- -- -- --
  • Which has Higher Returns XHE or PJP?

    Invesco Pharmaceuticals ETF has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    XHE
    SPDR S&P Health Care Equipment ETF
    -- -- --
    PJP
    Invesco Pharmaceuticals ETF
    -- -- --
  • What do Analysts Say About XHE or PJP?

    SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than Invesco Pharmaceuticals ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    XHE
    SPDR S&P Health Care Equipment ETF
    0 0 0
    PJP
    Invesco Pharmaceuticals ETF
    0 0 0
  • Is XHE or PJP More Risky?

    SPDR S&P Health Care Equipment ETF has a beta of 1.047, which suggesting that the stock is 4.673% more volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.502, suggesting its less volatile than the S&P 500 by 49.771%.

  • Which is a Better Dividend Stock XHE or PJP?

    SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.07%. Invesco Pharmaceuticals ETF offers a yield of 1.16% to investors and pays a quarterly dividend of $0.27 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XHE or PJP?

    SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XHE
    SPDR S&P Health Care Equipment ETF
    -- -- -- --
    PJP
    Invesco Pharmaceuticals ETF
    -- -- -- --
  • Which has Higher Returns XHE or XBI?

    SPDR S&P Biotech ETF has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    XHE
    SPDR S&P Health Care Equipment ETF
    -- -- --
    XBI
    SPDR S&P Biotech ETF
    -- -- --
  • What do Analysts Say About XHE or XBI?

    SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than SPDR S&P Biotech ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    XHE
    SPDR S&P Health Care Equipment ETF
    0 0 0
    XBI
    SPDR S&P Biotech ETF
    0 0 0
  • Is XHE or XBI More Risky?

    SPDR S&P Health Care Equipment ETF has a beta of 1.047, which suggesting that the stock is 4.673% more volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 0.917, suggesting its less volatile than the S&P 500 by 8.345%.

  • Which is a Better Dividend Stock XHE or XBI?

    SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.07%. SPDR S&P Biotech ETF offers a yield of 0.04% to investors and pays a quarterly dividend of $0.01 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XHE or XBI?

    SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XHE
    SPDR S&P Health Care Equipment ETF
    -- -- -- --
    XBI
    SPDR S&P Biotech ETF
    -- -- -- --
  • Which has Higher Returns XHE or XPH?

    SPDR S&P Pharmaceuticals ETF has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat SPDR S&P Pharmaceuticals ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    XHE
    SPDR S&P Health Care Equipment ETF
    -- -- --
    XPH
    SPDR S&P Pharmaceuticals ETF
    -- -- --
  • What do Analysts Say About XHE or XPH?

    SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than SPDR S&P Pharmaceuticals ETF, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than SPDR S&P Pharmaceuticals ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    XHE
    SPDR S&P Health Care Equipment ETF
    0 0 0
    XPH
    SPDR S&P Pharmaceuticals ETF
    0 0 0
  • Is XHE or XPH More Risky?

    SPDR S&P Health Care Equipment ETF has a beta of 1.047, which suggesting that the stock is 4.673% more volatile than S&P 500. In comparison SPDR S&P Pharmaceuticals ETF has a beta of 0.623, suggesting its less volatile than the S&P 500 by 37.686%.

  • Which is a Better Dividend Stock XHE or XPH?

    SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.02 per share corresponding to a yield of 0.07%. SPDR S&P Pharmaceuticals ETF offers a yield of 1.4% to investors and pays a quarterly dividend of $0.10 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. SPDR S&P Pharmaceuticals ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XHE or XPH?

    SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than SPDR S&P Pharmaceuticals ETF quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than SPDR S&P Pharmaceuticals ETF's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while SPDR S&P Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for SPDR S&P Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XHE
    SPDR S&P Health Care Equipment ETF
    -- -- -- --
    XPH
    SPDR S&P Pharmaceuticals ETF
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
77
VBTX alert for Jul 15

Veritex Holdings [VBTX] is down 0.21% over the past day.

Buy
72
MNPR alert for Jul 15

Monopar Therapeutics [MNPR] is down 1.28% over the past day.

Buy
56
NBIS alert for Jul 15

Nebius Group NV [NBIS] is up 2.12% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock